Title	Publication Date	Language	Citations
Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies	2012/08/01	English	314
From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis	2005/11/01	English	310
Functional disintegration in paranoid schizophrenia using resting-state fMRI	2007/12/01	English	304
Small-world networks and disturbed functional connectivity in schizophrenia	2006/10/01	English	301
Emotion and psychosis: Links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations	2006/09/01	English	292
Manual for the Extrapyramidal Symptom Rating Scale (ESRS)	2005/07/01	English	284
Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials	2011/04/01	English	279
Biosocial pathways to functional outcome in schizophrenia	2005/12/01	English	276
The relationship between brain structure and neurocognition in schizophrenia: a selective review	2004/10/01	English	274
Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis	2004/12/01	English	264
Functional resting-state networks are differentially affected in schizophrenia	2011/08/01	English	262
Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders	2008/02/01	English	261
Resting-state functional network correlates of psychotic symptoms in schizophrenia	2010/03/01	English	260
Psychosis risk screening with the Prodromal Questionnaire — Brief Version (PQ-B)	2011/06/01	English	258
Social cognition in schizophrenia: Relationships with neurocognition and negative symptoms	2007/02/01	English	258
Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up	2008/10/01	English	251
Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: Analysis of CATIE data	2012/05/01	English	250
Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12month and longer-term follow-ups	2013/09/01	English	250
The effects of antipsychotic therapy on serum lipids: a comprehensive review	2004/09/01	English	248
Mapping grey matter reductions in schizophrenia: An anatomical likelihood estimation analysis of voxel-based morphometry studies	2009/03/01	English	247
The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): Further description and extended norms	2006/02/01	English	247
Free radical pathology and antioxidant defense in schizophrenia: a review	1996/03/01	English	244
Facial affect recognition: A mediator between cognitive and social functioning in psychosis?	2006/07/01	English	244
The role of the insula in schizophrenia	2010/11/01	English	243
The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research	2020/08/01	English	243
Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: Systematic review and meta-analysis	2013/03/01	English	243
A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia	2007/02/01	English	242
How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression	2016/10/01	English	242
Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia	2004/12/01	English	242
The Health and Recovery Peer (HARP) Program: A peer-led intervention to improve medical self-management for persons with serious mental illness	2010/05/01	English	237